Mode
Text Size
Log in / Sign up

Type 5 diabetes in low-income populations with early malnutrition is underdiagnosed and needs standardized careType 5 Diabetes: A Hidden Threat in Poorer Nations

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider Type 5 diabetes in malnourished populations; standardized classification and protocols are urgently needed.

This narrative review addresses Type 5 diabetes mellitus, a form of diabetes linked to early-life malnutrition, particularly in low-income and middle-income populations in resource-constrained settings. The authors synthesize available literature to characterize this underrecognized condition.

Key findings include that Type 5 diabetes remains underdiagnosed and poorly understood, with no standardized classification or management protocols. The review emphasizes the need for research collaborations and region-specific approaches to improve diagnosis and care.

Limitations acknowledged include the overall poor understanding of the condition and the lack of robust data. The review does not report specific study populations, sample sizes, interventions, or outcomes, reflecting the nascent state of evidence.

For practice, the review suggests that clinicians in resource-constrained settings should consider Type 5 diabetes in patients with a history of early malnutrition, but standardized guidelines are lacking. Further research is needed to establish clear diagnostic criteria and treatment strategies.

A recent review highlights a little-known form of diabetes called Type 5 diabetes mellitus. This condition mainly affects people in low-income and middle-income countries who experienced malnutrition early in life. The review explains that Type 5 diabetes is often underdiagnosed because doctors may not recognize it. This means many people may not get the right treatment.

The review did not include new patient data or compare treatments. Instead, it looked at existing research to describe what is known about Type 5 diabetes. The authors note that this type of diabetes is not well understood. They call for better classification, more research, and specific management plans for affected regions.

There were no reports on safety or side effects because the review did not test any treatments. The main limitation is that Type 5 diabetes remains poorly studied. Readers should know that this is an early look at a condition that needs more attention. The review does not provide new evidence on how to treat or prevent it.

For now, the key message is that doctors in resource-limited settings should be aware of this form of diabetes. More research is needed to understand its causes and best treatments.

What this means for you:
Type 5 diabetes is underrecognized in poor regions; more research is needed.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
This review advocates for the formal recognition of Type 5 Diabetes Mellitus, a distinct, neglected form of non-autoimmune, lean diabetes predominantly affecting low-income and middle-income populations with a history of early-life malnutrition. Characterized by impaired insulin secretion amid preserved insulin sensitivity, this phenotype exhibits unique microarchitectural alterations within pancreatic islets and is strongly linked to malnutrition-induced epigenetic reprogramming and gut microbiota dysbiosis. Recent advancements in spatial omics technologies have illuminated region-specific gene expression, inflammatory pathways, and cellular remodeling in pancreatic tissue, offering novel insights into its pathophysiology. Despite its global prevalence, especially in resource-constrained settings, Type 5 diabetes remains underdiagnosed and poorly understood, hindering the development of tailored diagnostic criteria and therapeutic strategies. This review synthesizes current epidemiological, mechanistic, and molecular evidence, emphasizing the imperative for establishing standardized classification, research collaborations—including the formation of the IDF Type 5 Diabetes Working Group—and region-specific management protocols. Recognizing this disease entity is critical for advancing health equity, improving clinical outcomes, and guiding future research in metabolic disease frameworks.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.